New Kindle Book Published by Dr. Kevin Buckman -Find and Stop Breast Cancer-
(Newswire.net – January 25, 2013) Stockton, CA -- Viratech Corp. (OTC:VIRA) announced today that Cancer.im, has released the first of 235 books to be released on Amazon’s Kindle platform, focusing on Cancer. Cancer.im, a wholly owned subsidiary of Viratech Corp, is designed to be the world’s first experience based social network resource site for people affected by cancer
The first book, Find and Stop Breast Cancer by Dr. Kevin Buckman, will be offered through Amazon.com through its KDP Select program. With KDP Select, Amazon Kindle subscribers will be offered a free download of the book, for which Amazon.com will pay a portion of its KDP fund to Viratech for each download. “We developed the patent pending technologies for the Robert Ryan Cancer Protocol to decrease the morbidity in cancer patients and improving their quality of life,” states Dr. Kevin Buckman, CEO.
“Find and Stop Breast Cancer” features an in-depth description of how breast cancer starts in the ductal system of the breast. The abnormal cells surrounding tumor cells are what eventually evolve into invasive cells that carry cancer throughout the body. The book provides not only technical terms, but a layman’s understanding that answers questions, provides information and invites further reading and discovery of this dreaded disease.
Through its experience-based search engine and technology, Cancer.im's goal is to become the primary resource on the web for people affected by cancer, for the purpose of making a difference in their own lives and the lives of other Cancer.im's mission is to empower every cancer patient, regardless of their ability to pay, with the power to research their disease and to find, organize, and manage their own cancer support network. The goal of these support networks is to assist the patient in conserving needed energy by reducing the burden associated with their own daily trials and tribulations. Cancer.im will strive to convert this saved energy into a higher level of patient activity and a stronger determination to fight their disease.
Unlike other social networks, Cancer.im was designed by a team that is dedicated to specifically serve the unique needs of those currently struggling with the disease. This new network combines databases of medical community knowledge, repositories of wisdom from cancer survivors, systems for helping cancer patients organize their records and various facets of their treatment, and tools that allow patients and their supporters to work together effectively. In short, Cancer.im provides everything a cancer patient, friend, or family member is looking for to help in the fight against the disease, all in one online location and easy-to-use format.
Cancer.im technology can use its platforms and resources to help authors get book distribution thru its patented ways to use social networks, copyright protection, and create new markets for eBooks.
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform. This unique platform leveraging the utility of social collaboration, which will allow biotech cancer research to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Email Contact: firstname.lastname@example.org
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.